Citigroup’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$14.9M Buy
61,681
+27,052
+78% +$6.53M 0.01% 838
2025
Q1
$8.43M Buy
34,629
+13,635
+65% +$3.32M ﹤0.01% 1068
2024
Q4
$6.9M Sell
20,994
-1,507
-7% -$495K ﹤0.01% 1179
2024
Q3
$7.53M Sell
22,501
-4,014
-15% -$1.34M ﹤0.01% 1077
2024
Q2
$7.24M Buy
26,515
+14,646
+123% +$4M ﹤0.01% 1015
2024
Q1
$4.11M Buy
11,869
+240
+2% +$83K ﹤0.01% 1364
2023
Q4
$3.75M Sell
11,629
-1,508
-11% -$487K ﹤0.01% 1279
2023
Q3
$4.71M Sell
13,137
-1,799
-12% -$645K ﹤0.01% 1063
2023
Q2
$5.66M Sell
14,936
-4,009
-21% -$1.52M ﹤0.01% 1038
2023
Q1
$9.08M Buy
18,945
+3,091
+19% +$1.48M 0.01% 886
2022
Q4
$6.67M Sell
15,854
-2,287
-13% -$962K 0.01% 956
2022
Q3
$7.57M Buy
18,141
+3,851
+27% +$1.61M 0.01% 913
2022
Q2
$7.07M Sell
14,290
-3,070
-18% -$1.52M 0.01% 963
2022
Q1
$9.78M Buy
17,360
+1,259
+8% +$709K 0.01% 917
2021
Q4
$12.2M Sell
16,101
-1,796
-10% -$1.36M 0.01% 862
2021
Q3
$13.4M Sell
17,897
-3,513
-16% -$2.62M 0.01% 868
2021
Q2
$13.8M Sell
21,410
-2,972
-12% -$1.91M 0.01% 902
2021
Q1
$13.9M Buy
24,382
+3,998
+20% +$2.28M 0.01% 865
2020
Q4
$11.9M Buy
20,384
+501
+3% +$292K 0.01% 879
2020
Q3
$10.3M Sell
19,883
-6,928
-26% -$3.57M 0.01% 840
2020
Q2
$12.1M Buy
26,811
+16,311
+155% +$7.36M 0.01% 704
2020
Q1
$3.68M Sell
10,500
-1,445
-12% -$507K ﹤0.01% 1075
2019
Q4
$4.42M Buy
11,945
+3,446
+41% +$1.28M ﹤0.01% 1177
2019
Q3
$2.83M Sell
8,499
-5,579
-40% -$1.86M ﹤0.01% 1384
2019
Q2
$4.4M Sell
14,078
-368
-3% -$115K ﹤0.01% 1167
2019
Q1
$4.42M Buy
14,446
+8,478
+142% +$2.59M ﹤0.01% 1067
2018
Q4
$1.39M Sell
5,968
-3,395
-36% -$788K ﹤0.01% 1782
2018
Q3
$2.93M Buy
9,363
+3,091
+49% +$967K ﹤0.01% 1270
2018
Q2
$1.81M Sell
6,272
-1,390
-18% -$401K ﹤0.01% 1524
2018
Q1
$1.92M Sell
7,662
-35,423
-82% -$8.85M ﹤0.01% 1462
2017
Q4
$10.3M Buy
43,085
+21,518
+100% +$5.14M 0.01% 669
2017
Q3
$4.79M Buy
21,567
+16,241
+305% +$3.61M ﹤0.01% 985
2017
Q2
$1.21M Buy
5,326
+2,049
+63% +$464K ﹤0.01% 1831
2017
Q1
$653K Sell
3,277
-10,502
-76% -$2.09M ﹤0.01% 2250
2016
Q4
$2.51M Sell
13,779
-5,764
-29% -$1.05M ﹤0.01% 1638
2016
Q3
$3.2M Sell
19,543
-17,191
-47% -$2.82M ﹤0.01% 1126
2016
Q2
$5.25M Sell
36,734
-622
-2% -$89K 0.01% 784
2016
Q1
$5.11M Buy
37,356
+6,177
+20% +$845K 0.01% 815
2015
Q4
$4.32M Buy
31,179
+23,172
+289% +$3.21M ﹤0.01% 942
2015
Q3
$1.08M Buy
8,007
+1,524
+24% +$205K ﹤0.01% 1672
2015
Q2
$976K Sell
6,483
-549
-8% -$82.7K ﹤0.01% 1747
2015
Q1
$952K Buy
7,032
+1,517
+28% +$205K ﹤0.01% 1777
2014
Q4
$665K Buy
5,515
+1,724
+45% +$208K ﹤0.01% 2180
2014
Q3
$430K Sell
3,791
-649
-15% -$73.6K ﹤0.01% 2126
2014
Q2
$532K Buy
4,440
+914
+26% +$110K ﹤0.01% 1968
2014
Q1
$452K Buy
3,526
+35
+1% +$4.49K ﹤0.01% 2172
2013
Q4
$432K Sell
3,491
-166
-5% -$20.5K ﹤0.01% 2483
2013
Q3
$430K Sell
3,657
-1,333
-27% -$157K ﹤0.01% 2068
2013
Q2
$561K Buy
+4,990
New +$561K ﹤0.01% 1976